Palmer: Want To Make Racing Safer? Get Your COVID-19 Vaccine

As COVID-19 vaccine rollouts continue to ramp up across many racing states this week, New York State Gaming Commission equine medical director Dr. Scott Palmer said the best thing racing industry participants can do to make horses safer is to sign up for a shot.

Why?

Because in analyzing data on Thoroughbred fatalities from 2020, Palmer said he has determined the COVID-19 pandemic could be considered a novel risk factor for fatal injuries last year. Overall, there were 24 percent fewer fatalities per 1,000 starts in the region in 2020 as compared to 2019, but Palmer noticed some shifts in the types of fatalities that did occur. The number and percentage of overall fatalities that occurred during racing (versus training or other activities) went down, which Palmer said was to be expected since the pandemic pause resulted in resulted in fewer race cards in 2020 versus 2019.

He did see a change in the proportion of fatalities occurring in training, however – especially in juvenile runners.

“We had a very unusually high number of fatalities in 2-year-old racehorses, particularly at Saratoga Racetrack this summer,” said Palmer, who presented the data during a teleconference hosted by the Association of Racing Commissioners International. “There are always many factors that enter into fatalities and I'm not going to try to tell you COVID was the only reason for that, but you put COVID on top of a really crummy winter where it was tough to train anyway, and it wasn't like we could move the Saratoga meet back to September.”

Once racing was cancelled, Palmer said it didn't make sense for some owners that keep their horses on the farm to send them to the track as usual and pay a day rate when they had no idea how much longer racing would be shut down. Some 2-year-olds didn't post their first official timed works until June, much closer to their debuts than usual. Out of the eighteen 2-year-old fatalities in 2020, eight occurred in horses that had never made it to the races.

“That's a really big deal,” Palmer said. “That was an enormously different experience than we'd ever had before.”

Palmer pointed out that many horses, including those 2-year-olds, did not get the usual timeframe for the bone remodeling process which is crucial to preparing the skeleton for the rigors of racing.

(Read more about the way racing and training impacts the skeleton for young horses here.)

Equine (and human) skeletons undergo a constant cycle of response to environmental stressors, with the bone surface absorbing micro damage, then removing damaged bone cells and replacing them with new cells. In this way, the skeleton can respond dynamically to the stresses it undergoes, which is why a period of gradually-increasing workload ahead of a race prepares the horse for the rigors of running. The removal of damaged bone cells is quick, but Palmer said the creation of new, stronger bone is much slower. It's not always clear to a trainer where a horse is in the development process, since horses may appear sound throughout.

By the time horses did get to the races last year, many ran fewer times overall than they would normally have in a calendar year, reducing the opportunities for their skeletons to respond to intense exercise before the next race.

Palmer also reported that in New York, the pandemic had a serious impact on the number of out-of-competition tests (OOCT) that could be administered. OOCTs typically happen with two regulatory staff getting in a car together to collect the needed samples; during COVID-19, that kind of travel couldn't happen. It's hard to say whether trainers were using more medication out of competition to patch horses through a busy summer and fall because they simply weren't tested as much.

That's why he wants you to get vaccinated – horses, trainers, and regulatory veterinarians can only return to their regular duties as COVID-19 rates continue to come down and developing herd immunity will contribute to that, he said.

The Mid-Atlantic region has generally improved its fatality numbers with time; when expressed as a rate per 1,000 starts, racing-related fatalities are down 43 percent from 2010 to 2020, which officials find encouraging. For the first part of the decade though, the Mid-Atlantic tracked higher than the national average rate. Those rates have become more similar in the past five years, and while the national data from the Equine Injury Database is not yet published for 2020, Palmer expects they will once again be very close. The racing fatality rate in the Mid-Atlantic for 2020 was 1.39 per 1,000 starts.

The way numbers are expressed makes a big difference in their specificity and their context for regulators, and Palmer said the public and the media do not always grasp the importance of this. For example, New York saw 24 fatalities from 14,895 racing starts last year, and 42 fatalities from timed workouts; that would make it seem as though working out is more dangerous than racing in New York, but leaves out the context that there were 49,073 official timed workout events. The state's racing fatality rate was 1.6 per 1,000 starts, but its training fatality rate was 0.8 per 1,000 timed workouts. Expressing numbers as rates also makes it easy to compare data between years like 2019 and 2020 when the state had drastically different numbers of races.

The EID has yielded numerous reforms to improve racing safety, but Palmer said commissions need to begin focusing on making appropriate changes in the morning, too.

“We don't regulate training in the same way we regulate racing,” Palmer pointed out.

Even in jurisdictions where there are regulatory veterinarians observing morning training, there may not be enough of them to visually cover all parts of a track, and it's easy for a trainer to sneak a horse with questionable soundness through a different gap before the sun is up.

Video surveillance can help veterinarians pick up on problems (though, citing the case of Mongolian Groom ahead of the 2019 Breeders' Cup, Palmer pointed out it's only as good as the monitoring of that video).

Palmer believes regulators need a better idea of how much medication horses have on board for timed workouts; he pointed to California's recently-updated rules prohibiting non-steroidal anti-inflammatories within 24 hours of a timed work and subjecting horses to post-work sampling to verify compliance. Even if a jurisdiction doesn't have that rule, Palmer suggested random sampling as a fact-finding endeavor, as well as sampling any training fatalities.

Palmer also suggested that track maintenance become a priority in the mornings. He recently conducted a study of moisture levels at Belmont and found significant differences between the main and training track. During a drought, it's difficult to keep New York's sand-heavy track surfaces sufficiently watered in the afternoons, but the water trucks and harrows can make much more frequent passes over the surface than they can in the afternoon.

Data showed the main track surface at Belmont is considerably wetter than the training track surface.

“Is that good? Is that bad?” he said. “I have no idea … what I do know is we want to have a consistent surface for all horses and I'd submit to you that this is not as consistent as it needs to be.”

The final component for improved safety, according to Palmer's recommendations: mandated continuing education for licensed trainers, to make sure those who might miss this story have all the information they need.

Currently, trainer CE will be required in Delaware, Maryland, New York, and Virginia in 2022. It will be a condition pending legislative approval next year in West Virginia, and is still “under consideration” in New Jersey and Pennsylvania.

The post Palmer: Want To Make Racing Safer? Get Your COVID-19 Vaccine appeared first on Horse Racing News | Paulick Report.

Source of original post

Report: 77 Percent Of New York Thoroughbreds From Indicted Trainers Were Positive For Clenbuterol After Arrests

At a press conference this week, New York State Gaming Commission equine medical director Dr. Scott Palmer revealed that the majority of New York-based Thoroughbreds with trainers under federal indictment tested positive for clenbuterol in the weeks after the March arrests that rocked the racing world.

Standardbreds and Thoroughbreds that were trained by anyone named in the March indictment of more than two dozen trainers, veterinarians, and drug distributors in an alleged doping scheme were put on the veterinarian's list for 60 days and had biological samples taken for testing. Palmer said this week that the horses were tested at least twice during this period. Of nearly 100 Thoroughbreds based in the New York at the time, Palmer said 77 had levels of clenbuterol in their blood.

Though Palmer is still compiling veterinary records for some of those horses, so far he says none of those records show administration of clenbuterol. That leads him to suspect the drug was not being given as part of a legitimate treatment for a diagnosed condition, but rather for its side effects, which mimic anabolic steroids with repeated usage.

Palmer called the discovery “concrete evidence that clenbuterol was being widely abused in the Thoroughbred horses,” according to the Thoroughbred Daily News.

This isn't the first time testing has revealed widespread clenbuterol usage by the indicted trainers. In September, Kentucky Horse Racing Commission equine medical director Dr. Bruce Howard revealed that similar testing on Kentucky-based horses resulted in “a near 100 percent rate” of clenbuterol administration based on hair testing. Howard said that separately, treatment sheets submitted to the Kentucky commission as part of its veterinary disclosure rules have shown incidents of veterinarians prescribing the drug to entire barns.

Palmer said Mid-Atlantic states will likely tighten restrictions around clenbuterol administration.

Clenbuterol was one of several substances described in federal court documents as being favored by defendants for its performance-enhancing effects. Most of the other drugs listed there, such as EPO-like substances and “pain blockers,” are not permitted in active racehorses at all.

Read more at Thoroughbred Daily News

The post Report: 77 Percent Of New York Thoroughbreds From Indicted Trainers Were Positive For Clenbuterol After Arrests appeared first on Horse Racing News | Paulick Report.

Source of original post

NY Horses from Federally Indicted Trainers Were Positive for Clenbuterol at 77%

Beyond the relatively obscure and exotic performance-enhancing drugs allegedly administered to the Thoroughbreds of federally indicted trainers who were charged in March in a years-long doping racket, subsequent testing on the New York contingent of those horses revealed 77% of them had clenbuterol in their systems.

And because medical records associated with those Thoroughbreds didn’t indicate that drug was administered for its intended purpose (to treat a medically legitimate airway disease), New York State Gaming Commission equine medical director Scott Palmer, VMD, said that the study he conducted on that set of horses offers proof that clenbuterol has been widely abused to bulk up horses, allowing their trainers to gain a pharmaceutical edge that makes the animals stronger and faster.

Palmer’s comments came during a Nov. 11 video press conference hosted by stakeholders and regulators who make up a Mid-Atlantic alliance of racing interests. His revelations about clenbuterol were just one example of how that group has been advancing a safety-centric agenda aimed at reducing equine fatalities in the region, which includes racing jurisdictions in New York, Delaware, Maryland, New Jersey, Pennsylvania, Virginia, and West Virginia.

That study on clenbuterol that Palmer worked on also bolstered the Mid-Atlantic alliance’s recent push to eliminate the allowable race-day threshold for clenbuterol. On Oct. 22, the Maryland Racing Commission took the first steps toward turning that initiative into a new rule, and Palmer said on Wednesday other regional states are in the pipeline to follow.

Trainer Jason Servis, Jorge Navarro, and 22 others in both the Thoroughbred and Standardbred industries are facing federal charges in an alleged “widespread, corrupt scheme” dating to at least 2017 that centers on a vast network of co-conspirators who purportedly manufactured, mislabeled, rebranded, distributed and administered performance-enhancing drugs to racehorses all across America and in international races.

Palmer explained that when the indictments and arrests were first made public back in March, he took it as an opportunity to try and detect what other, more commonplace, substances were being used as performance-enhancers. He said he suspected clenbuterol because of the bronchodilator medication’s well-known, off-label potential for abuse as a substance that delivers similar lean muscle-building results as anabolic steroids.

“There was a whole list that the FBI generated through wiretapping these people that came up with a lot of medications,” Palmer said. “When I reviewed that list, certainly a lot of it looked to me like a ‘snake-oil’ situation where I wasn’t convinced that the things on that list were really making much of a [performance enhancement] difference. But I was concerned that there were other things that might be given to these horses that didn’t show up on the indictment list that could be a big factor.

“One of them was clenbuterol,” Palmer continued. “Clenbuterol is a drug that has, in addition to its ability to affect lower airway disease and improve it, [an ability to act as] a repartitioning agent [that] is used in humans for body-building effects. It’s basically an end-run around on our anabolic steroid ban, and so I was very interested in proving that.”

Palmer said he required New York-based Thoroughbreds and Standardbreds from the barns of indicted trainers to be placed on the stewards’ list, adding that other jurisdictions did the same. Specimen samples were taken, the horses had to be out of competition for about a month while analysis was performed, and then had to have workouts approved by a commission veterinarian and pass yet another drug test before they would be allowed to race for new conditioners.

This process took about 60 days total, and Palmer said that in New York, nearly 200 Standardbreds and almost 100 Thoroughbreds were tested twice in this manner.

“In the Thoroughbred breed, 77% of those horses [initially] had levels of clenbuterol in their blood,” Palmer said. “[We then] asked for the medical records on these horses. We haven’t gotten through them all yet, but we haven’t found any that had clenbuterol administration listed in their medical records. That’s a strong indication that this drug is being given for purposes other than the normal prescribed reason for giving clenbuterol.”

After years of speculation, Palmer said, “we had concrete evidence that clenbuterol was being widely abused in the Thoroughbred horses.”

Armed with that information, the Mid-Atlantic alliance of racetracks, horsemen’s groups and regulators set about making the case for stricter clenbuterol regulations.

“It’s going to be introduced in New York shortly, and it’s going to be widely adopted in the Mid-Atlantic region,” Palmer said.

Also during Wednesday’s press conference, the alliance announced that the equine fatality rate in the region has dropped from 1.78 per thousand starts in 2019 to 1.21 per thousand to date so far this year, a decrease of 33%.

“It is heartening to see that the commitment and hard work of so many in the Mid-Atlantic is bearing fruit,” said Alan Foreman, the chairman and chief executive officer of the Thoroughbred Horsemen’s Association. “We have representatives from every faction of the Thoroughbred industry in the region at the table. Everyone has the chance to be heard and their specific issues considered. We are proud to say that, working together, we have been able to make significant advances on issues of medication reform and horse health.”

Among those changes, every state in the Mid-Atlantic alliance has adopted the following reforms:

  • A prohibition on non-steroidal anti-inflammatory drug (NSAID) “stacking” (the use of more than one NSAID in the week of a race).
  • Transfer of joint injection records for claimed horses.
  • Necropsies on equine fatalities and a mortality review board.
  • Voidable claim rules.

Additional reforms have been implemented in all states except West Virginia, including:

  • 48-hour withdrawal time for NSAIDs.
  • Enhanced penalties for NSAID overages.
  • 14-day withdrawal for joint injections

There is a strict prohibition on the use of bisphosphonates in all horses under the age of four throughout the region, with a total ban in place in Maryland and Pennsylvania.

The post NY Horses from Federally Indicted Trainers Were Positive for Clenbuterol at 77% appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Mid-Atlantic Sees Significant Drop In Racing Fatalities Following Reforms

COVID-19 forced Thoroughbred racing into what was for most a two-month hiatus, but the stakeholders in the Mid Atlantic turned the down time into an opportunity to focus on its Strategic Plan to Reduce Equine Fatalities.

Regulators, racetracks, horsemen's and breeders' groups representing all seven states in the region – Delaware, Maryland, New Jersey, New York, Pennsylvania, Virginia, and West Virginia – committed to the Mid-Atlantic Strategic Plan to Reduce Equine Fatalities in 2019. Collectively, they have been working to adopt regulations, protocols and best practices to enhance the safety and integrity of the sport. Their efforts are having an impact. The equine fatality rate in the region has dropped from 1.78 per thousand starts in 2019, to 1.21 per thousand to date this year, a decrease of 33%.

The architects of the Strategic Plan, Thoroughbred Horsemen's Association Chairman Alan Foreman and New York State Equine Medical Director Dr. Scott Palmer, provided a progress report on the efforts of the Mid-Atlantic stakeholders Wednesday.

“It is heartening to see that the commitment and hard work of so many in the Mid Atlantic is bearing fruit,” Foreman said. “We have representatives from every faction of the Thoroughbred industry in the region at the table. Everyone has the chance to be heard and their specific issues considered. We are proud to say that, working together, we have been able to make significant advances on issues of medication reform and horse health.”

Dr. Palmer remarked, “In a climate of polarity and discord, the efforts in the Mid Atlantic serve as a shining example of what we can accomplish when we are united behind the cause of equine safety and welfare.”

Every state in the Mid Atlantic has adopted the following reforms:

  • A prohibition on NSAID “stacking” – the use of more than one NSAID the week of a race
  • Transfer of joint injection records for claimed horses
  • Necropsies on equine fatalities
  • Mortality Review Board
  • Voidable claim rules

Dr. Tim Parkin, a renowned epidemiologist from the University of Glasgow, released the findings of his latest study using data from The Jockey Club's Equine Injury Database in June, noting that those tracks that have instituted a void claim rule in the last 10 years saw a 27% decrease in equine fatalities for those races. The states in the Mid Atlantic have all implemented this additional layer of protection; claims are voidable at the discretion of the claimant if the horse is vanned from the track after the race or is observed to be lame prior to delivery to the new trainer.

Additional reforms have been implemented in all states except West Virginia, including:

  • 48-hour withdrawal time for NSAIDs
  • Enhanced penalties for NSAID overages
  • 14-day withdrawal for joint injections

The West Virginia Racing Commission considered legislation to adopt the new guidelines for NSAIDs and joint injections, but it ultimately was voted down by the Commission.

“We are disappointed that West Virginia remains an outlier in this area,” Foreman said. “Regulatory changes in the state must go through the legislature, which takes time, but we will continue to work with all parties to get this done.”

There is a strict prohibition on the use of bisphosphonates in all horses under the age of four throughout the region, with a total ban in place in Maryland and Pennsylvania. In May, the Mid Atlantic agreed to adopt restrictions on the use of thyroid supplements, now requiring that a horse be diagnosed with hypothyroidism through a thyroid releasing hormone stimulation test; the treatment plan must be reviewed and approved by the equine medical director or chief regulatory veterinarian in the state. In October, the group moved to restrict the use of clenbuterol. The new rule requires regulatory approval for treatment with clenbuterol, mandates that the horse be placed on the Veterinarian's List, and bars the horse from racing until it tests negative in both blood and urine and completes a satisfactory workout observed by a regulatory veterinarian.

In addition to the regulatory changes, the Mid Atlantic has approved Best Practices in a dozen areas, including:

  • Biosecurity
  • Crisis Management Communication
  • Equine Aftercare
  • Layoff Report
  • Pre-Race Inspections
  • Safety Officer
  • Shock Wave Therapy

Maryland led the charge on the mandatory Layoff Report, a standardized form that provides regulatory veterinarians with vital information for all horses that have not raced for 150 days or more, including the reason for the layoff, medication and joint injection records, and surgical reports. The Layoff Report has been fully implemented in Delaware, Maryland, Virginia and West Virginia, and is in process throughout the Mid Atlantic.

The most high-profile of this year's changes has been the crop rule. The stakeholders in support of the Strategic Plan created a Committee of 24 regulators and stewards to review the many proposals on the table. All interested parties were invited to participate, with the Jockeys' Guild providing significant input during a series of conference calls. A draft was approved during a presentation to more than 50 representatives of the region's racetracks, horsemen's groups and regulatory agencies.

The draft underwent one final review after the Kentucky Horse Racing Commission approved a rule June 19, and was modified once more to align with provisions in the Kentucky rule. Starting Aug. 1, the rule went into effect in Delaware and Maryland. Pennsylvania followed suit in October. West Virginia has begun the legislative process necessary to adopt it in 2021.

“Uniformity has been a hallmark of the efforts in the Mid Atlantic for more than a decade, going back to the ban on anabolic steroids in 2008,” Foreman said. “Our annual Regulatory meetings have grown year after year, with the focus expanding from medication and testing to include equine welfare and racing integrity. The crop rule is a natural extension of our efforts. We felt it imperative to have a consistent crop rule in every jurisdiction, and we made every effort to ensure that all stakeholders had the chance to weigh in on it.”

A 30-page Strategic Plan Manual, still a work in progress, has been created as a reference for all Mid-Atlantic jurisdictions. There is also a Horsemen's Guide to the Strategic Plan, providing an overview of the regulations and best practices that impact the day-to-day business of training Thoroughbred racehorses.

A second Guide outlines the Risk Factors that have been identified through Dr. Parkin's work with the Equine Injury Database and the Grayson-Jockey Club Research Foundation, which horsemen can use to assess their stable and modify care and treatment as necessary for horses at increased risk.

“From day one when concept of the Strategic Plan was first under discussion, this has been a collaborative effort, with all of our stakeholders focused on one thing – doing what is right by the horse,” said the Strategic Plan's Project Manager, Andy Belfiore. “The level of dedication and the amount of time and energy devoted to this initiative from all involved has been remarkable. It has taken a lot of work from the regulators and the state veterinarians, to racetrack's management teams, to the owners and trainers and jockeys, to get to where we are today.”

As the first phase of the Strategic Plan nears completion, the focus turns to the topics including the racetrack maintenance quality system; jockey health; the transfer of horse health records for all claimed horses; and continuing education.

Dr. Kelly Ryan of MedStar Horsemen's Health in Maryland worked with HeadCheck Health to develop a system that establishes concussion protocols for jockeys, as well as providing a HIPAA-compliant portal for jockey health information, and a communications network to ensure that all racetracks on the system are notified if there is an accident or injury affecting a jockey's status to ride. Maryland began a pilot program last fall, and Delaware Park enrolled its riders when racing resumed this spring. Additional jurisdictions are now working with HeadCheck to explore implementation, with the goal of having every Mid-Atlantic racetrack on the network by next year.

The Mid-Atlantic alliance unanimously approved a Continuing Education rule that will go into effect in 2021. Trainers and assistant trainers will have a year to fulfill the requirements, which include four hours annually of CE training, with a minimum of two hours to focus on equine health, safety and welfare. Fulfillment of CE requirements will be a condition of licensing in 2022 for all Mid-Atlantic states. New York already has a CE rule on the books, Maryland has begun the adoption process, West Virginia included it in its legislative package for 2021, and the remaining states have committed to adoption next year.

“New York has been a leader in many areas, including Continuing Education, but the Mid-Atlantic Strategic Plan is not about one jurisdiction calling the shots for the entire region,” Dr. Palmer concluded. “Working together, we have been able to reach consensus. We have right-minded people in the room who want to do the right thing, and we have a track record for getting things done. What we've accomplished is amazing, and we look forward to continued progress in the coming year.”

The post Mid-Atlantic Sees Significant Drop In Racing Fatalities Following Reforms appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights